IROG

Instructions to Authors

SUBMISSION OF MANUSCRIPTS

Papers should be submitted to M. MARCHETTI, Editor-in-Chief of European Journal of Gynaecological Oncology – EJGO through the online submission system (OSS). Please proceed to http://www.irog.net/author or CLICK HERE TO SUBMIT A NEW MANUSCRIPT. You must then register. Paper manuscripts and e-mail submissions will no longer be accepted.

Editorial articles for publication in the Distinguished Expert Series should be submitted to P. Bősze, Editor-in-Chief. Address: Department of Gynecology, Tel. (+36-1) 275-2172 - Fax (+36-1) 275-2172 - e-mail: bosze@eagc.eu

Corresponding Authors must register through the OSS when submitting a manuscript, at which time they will be prompted to create a username and password for access to their home page (this information should be retained to avoid creating duplicate accounts). From the home page, Authors will have access to the status of their manuscripts throughout the editorial process and, therefore, login and passwords need to be retained for future reference. All correspondence, including notification of the Editor's decision and requests for revision will take place by e-mail and via the Author's home page. Any queries concerning the submission process or Journal procedures should be sent by the Corresponding Author to irog.canada@gmail.com. The e-mail address of the Corresponding Author must be registered correctly and should be updated via the OSS if it changes. All correspondence regarding the submission will only be sent to this e-mail address.

Once manuscripts are correctly uploaded, they will undergo initial screening by the Editor-in-Chief and Peer Referees. To ensure timely processing of the large number of submissions received, manuscripts that do not meet the Journal's requirements will be withheld without Peer review, and the Corresponding Author will receive notification of the missing requirements by e-mail. All other manuscripts will undergo Peer review and an official letter of acknowledgement will be sent to the Corresponding Author within eight weeks. Authors may be required to modify the manuscript according to the Reviewers’ suggestions.

Manuscripts accepted for publication will be copyedited by the Editorial staff for typographical and grammatical mistakes and to guarantee clarity and conciseness. Accepted manuscripts may not be published before eight to 12 months, depending on the number of accepted papers and on the scientific and publishing requirements. Published papers will become property of EJGO and copyrighted under 7847050 CANADA Inc. After six months, no grievances s will be accepted regarding published articles. All statements are the responsibility of the Authors. Product dosages, indications, and methods referred in the papers reflect the authors’ experience. No responsibility is assumed by the Editor-in-Chief or the Publisher for any damage from the use of any products, operation methods or instructions contained in the published materials. Trade names, trademarks, etc. are protected and regulated by laws and regulations and are generally not included in the publications. The Editor-in-Chief and the Publisher cannot accept any legal responsibility for any errors or omissions that may be made in press, particularly for information about drug dosage and application thereof contained in the Journal. Prescribing information should be consulted before administering any drug.

MANUSCRIPT REQUIREMENTS

EJGO follows the “Uniform requirements for manuscripts submitted to biomedical journals” drawn up by the International Committee of Medical Journal Editors (ICMJE). One manuscript, typed, and double-spaced in MS Word or RTF format should be uploaded through the OSS: http://www.irog.net/author. A cover letter signed by all Authors must state that all have participated in the work and assume responsibility for the manuscript which has never been published or submitted for publication elsewhere. Online submissions cannot be completed without a cover letter.

After the title page (full title and all authors’ complete professional identifications/academic titles, affiliations/institutions in English), original works should be arranged in the conventional order: Summary (Purpose of investigation, Materials and Methods, Results, Conclusion - about 150 words), Key words, Content (a 20-word summary), Introduction, Materials and Methods, Results, Discussion, Conclusion, Acknowledgement (if any will be limited to appropriate professionals who were contributors to the paper or to eventual financial support received), and References should be numbered consecutively in the order in which they are first mentioned in the text. References in the text, tables, and legends should be identified by Arabic numerals in parentheses. The author list should include up to six authors before “et al.” unless the total number of authors is seven, in which case all should be listed. The surnames should appear first and then the initial(s). The examples of references listed below are based on slight modifications on the format used by the U.S. National Library of Medicine in Index Medicus. The titles of the Journals should be abbreviated according to Index Medicus and should appear in italic form. These are then followed by the year, volume number in italic form, and only the first page of the article or chapter. References must be verified by the Author(s) against the original documents.

 

Examples of correct style and punctuation of references are the following:

 

Articles in Journals:

Check J.H., Cohen G., Cohen R., Dipietro J., Steinberg B.: “Sympathomimetic amines effectively control pain for interstitial cystitis that had not responded to other therapies”. Clin. Exp. Obstet. Gynecol., 2013, 40, 227.

 

Chapter in a Book:

Permuth-Wey J., Besharat A., Sellers T.A.: “Epidemiology of ovarian cancer: an update”. In: Farghaly S.A., (ed). Advances in diagnosis and management of ovarian cancer. New York: Springer, 2013, 1.  

 

Tables should have a title, be typed, and double-spaced on separate pages and numbered in Arabic numerals in the order of their first citation in the text. Only standard and universally understood abbreviations should be used.

Figures should be numbered consecutively and will be printed in colour or in black and white according to the Authors’ preferences, as printing costs will vary according to this preference. Figure legends should appear on a separate page with Arabic numerals corresponding to them.

Throughout the text only standard abbreviations can be used and must be avoided in the title. The full term for which an abbreviation stands should precede its first use in the Summary and text unless it is a standard unit of measurement.

 

PROOFS will revised by the Editorial Staff will be sent to the Corresponding Author and should be checked for any typesetting errors. Any eventual corrections considered essential should be made directly on the proofs and then signed, scanned, and returned within 20 days through the OSS. Signed proofs are a prerequisite for publication and confirm their acceptance and waives the Publisher from any eventual error due to oversight. The authors' initials and surnames should also be checked. Changes in authorship are no longer possible once proofs are received.

 

BUSINESS MATTERS

EJGO includes no commercial advertisements and does not receive any external funding. Authors will be kindly asked to contribute to the editing and printing expenses. Once an article is published, the Corresponding Author will receive a complementary PDF copy by e-mail and the issue in which it appears by regular mail. Only payments in USD will be accepted. Reprints should be requested with the form enclosed with the acceptance letter and can be paid by credit card, bank transfer or online by PayPal. Authors should include a complete mailing address and e-mail for reprint requests.


 

SUBMISSION OF MANUSCRIPTS

Papers should be submitted to M. MARCHETTI, Editor-in-Chief of Clinical and Experimental Obstetrics & Gynecology – CEOG through the online submission system (OSS). Please proceed to http://www.irog.net/author or CLICK HERE TO SUBMIT A NEW MANUSCRIPT. You must then register. Paper manuscripts and e-mail submissions will no longer be accepted.

The Reproductive Biology Section is led by J.H. CKECK, Editor-in-Chief. Address: Reproductive and Medical Endocrine Associates P.C. (Attention: Laurie Aurand), 7447 Old York Road, Melrose Park, PA 19027 (USA). Tel. +1-215-635-4400 - Fax +1-215-635-2304 - e-mail laurie@ccivf.com.

Corresponding Authors must register through the OSS when submitting a manuscript, at which time they will be prompted to create a username and password for access to their home page (this information should be retained to avoid creating duplicate accounts). From the home page, Authors will have access to the status of their manuscripts throughout the editorial process and, therefore, login and passwords need to be retained for future reference. All correspondence, including notification of the Editor's decision and requests for revision will take place by e-mail and via the Author's home page. Any queries concerning the submission process or Journal procedures should be sent by the Corresponding Author to irog.canada@gmail.com. The e-mail address of the Corresponding Author must be registered correctly and should be updated via the OSS if it changes. All correspondence regarding the submission will only be sent to this e-mail address. Once manuscripts are correctly uploaded, they will undergo initial screening by the Editor-in-Chief and Peer Referees. To ensure timely processing of the large number of submissions received, manuscripts that do not meet the Journal's requirements will be withheld without Peer review, and the Corresponding Author will receive notification of the missing requirements by e-mail. All other manuscripts will undergo Peer review and an official letter of acknowledgement will be sent to the Corresponding Author within eight weeks. Authors may be required to modify the manuscript according to the Reviewers’ suggestions.

Manuscripts accepted for publication will be copyedited by the Editorial staff for typographical and grammatical mistakes and to guarantee clarity and conciseness. Accepted manuscripts may not be published before eight to 12 months, depending on the number of accepted papers and on the scientific and publishing requirements. Published papers will become property of CEOG and copyrighted under 7847050 CANADA Inc. After six months, no grievances will be accepted regarding published articles. All statements are the responsibility of the Authors. Product dosages, indications, and methods referred in the papers reflect the authors’ experience. No responsibility is assumed by the Editor-in-Chief or the Publisher for any damage from the use of any products, operation methods or instructions contained in the published materials. Trade names, trademarks, etc. are protected and regulated by laws and regulations and are generally not included in the publications. The Editor-in-Chief and the Publisher cannot accept any legal responsibility for any errors or omissions that may be made in press, particularly for information about drug dosage and application thereof contained in the Journal. Prescribing information should be consulted before administering any drug.

 

MANUSCRIPT REQUIREMENTS

CEOG follows the “Uniform requirements for manuscripts submitted to biomedical journals” drawn up by the International Committee of Medical Journal Editors (ICMJE). One manuscript, typed, and double-spaced in MS Word or RTF format should be uploaded through the OSS: http://www.irog.net/author. A cover letter signed by all Authors must state that all have participated in the work and assume responsibility for the manuscript which has never been published or submitted for publication elsewhere. Online submissions cannot be completed without a cover letter.

After the title page (full title and all authors’ complete professional identifications/academic titles, affiliations/institutions in English), original works should be arranged in the conventional order: Summary (Purpose of investigation, Materials and Methods, Results, Conclusion - about 150 words), Key words, Content (a 20-word summary), Introduction, Materials and Methods, Results, Discussion, Conclusion, Acknowledgement (if any will be limited to appropriate professionals who were contributors to the paper or to eventual financial support received), and References should be numbered consecutively in the order in which they are first mentioned in the text. References in the text, tables, and legends should be identified by Arabic numerals in parentheses. The author list should include up to six authors before “et al.” unless the total number of authors is seven, in which case all should be listed. The surnames should appear first and then the initial(s). The examples of references listed below are based on slight modifications on the format used by the U.S. National Library of Medicine in Index Medicus. The titles of the Journals should be abbreviated according to Index Medicus and should appear in italic form. These are then followed by the year, volume number in italic form, and only the first page of the article or chapter. References must be verified by the Author(s) against the original documents.

 

Examples of correct style and punctuation of references are the following:

 

Articles in Journals:

Check J.H., Cohen G., Cohen R., Dipietro J., Steinberg B.: “Sympathomimetic amines effectively control pain for interstitial cystitis that had not responded to other therapies”. Clin. Exp. Obstet. Gynecol., 2013, 40, 227.

 

Chapter in a Book:

Permuth-Wey J., Besharat A., Sellers T.A.: “Epidemiology of ovarian cancer: an update”. In: Farghaly S.A., (ed). Advances in diagnosis and management of ovarian cancer. New York: Springer, 2013, 1.  

 

Tables should have a title, be typed, and double-spaced on separate pages and numbered in Arabic numerals in the order of their first citation in the text. Only standard and universally understood abbreviations should be used.

Figures should be numbered consecutively and will be printed in colour or in black and white according to the Authors’ preferences, as printing costs will vary according to this preference. Figure legends should appear on a separate page with Arabic numerals corresponding to them.

Throughout the text only standard abbreviations can be used and must be avoided in the title. The full term for which an abbreviation stands should precede its first use in the Summary and text unless it is a standard unit of measurement.

 

PROOFS will revised by the Editorial Staff will be sent to the Corresponding Author and should be checked for any typesetting errors. Any eventual corrections considered essential should be made directly on the proofs and then signed, scanned, and returned within 20 days through the OSS. Signed proofs are a prerequisite for publication and confirm their acceptance and waives the Publisher from any eventual error due to oversight. The authors' initials and surnames should also be checked. Changes in authorship are no longer possible once proofs are received.

 

BUSINESS MATTERS

CEOG includes no commercial advertisements and does not receive any external funding. Authors will be kindly asked to contribute to the editing and printing expenses. Once an article is published, tthe Corresponding Author will receive a complementary PDF copy by e-mail and the issue in which it appears by regular mail. Only payments in USD will be accepted. Reprints should be requested with the form enclosed with the acceptance letter and can be paid by credit card, bank transfer or online by PayPal. Authors should include a complete mailing address and e-mail for reprint requests.